
|Articles|April 13, 2020
Glaucoma 360: Glaucoma devices update with Victor Chan, MB, MS (Santen Inc)
Author(s)Alex Delaney-Gesing
Advertisement
Victor Chan, MBA, MS, director of U.S. Surgical Device Commercial Marketing at Santen, Inc., offers insight on the Glaucoma Devices panel discussion regarding new innovations and diagnostic devices during Glaucoma 360 2020 in San Francisco, California.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Positive pediatric data emerge from the OPGx-LCA5 phase 1/2 trial of Leber congenital amaurosis type 5
2
Researchers assess atropine and cyclopentolate for detecting premyopia in young children
3
Q&A: Patricio Schlottmann discusses results of AVONELLE-X faricimab extension trial
4
Q&A: Alexandra Miere discusses the ACTOR and HERMES studies
5